Background Growing evidence indicates that RNA methylation plays a fundamental role in
epigenetic regulation, which is associated with the tumorigenesis and drug resistance …

Acute myeloid leukemia (AML) is an aggressive hematological tumor caused by the
malignant transformation of myeloid progenitor cells. Although intensive chemotherapy …

Acute myeloid leukemia (AML) is one of the most aggressive hematopoietic malignancies.
Patients still suffer from refractory/relapsed disease after anthracycline-based therapy, which …

Introduction Acute myeloid leukemia (AML) is a type of blood cancer that is identified by the
unrestricted growth of immature myeloid cells within the bone marrow. Despite therapeutic …

ABSTRACT N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the
most common and abundant modification in mammalian mRNAs and non-coding RNAs …

Background N6-methyladenosine (m6A) methylation epigenetically regulates normal
hematopoiesis and plays a role in the pathogenesis of acute myeloid leukemia (AML) …

Acute myeloid leukemia (AML) is a hematologic malignancy with an unfavorable prognosis.
A better understanding of AML pathogenesis and chemotherapy resistance at the molecular …

Accumulating studies have indicated that N6-methyladenosine (m 6 A) plays an important
role in acute myeloid leukaemia (AML). However, little is known about the m 6 A methylome …

Background: Acute myelocytic leukemia (AML) is one of the hematopoietic cancers with an
unfavorable prognosis. However, the prognostic value of N 6-methyladenosine-associated …

Background Most previous studies have focused on the intrinsic carcinogenic pathways of
tumors; however, little is known about the potential role of N6-methyladenosine (m6A) …